Insider Trading Activity BioScrip, Inc. (NASDAQ:BIOS) – Director Sold 886,478 shares of Stock

ME Staff
-
0

Insider Trading Activity For BioScrip, Inc. (NASDAQ:BIOS)

Coliseum Capital Management, L , Director of BioScrip, Inc. (NASDAQ:BIOS) reportedly Sold 886,478 shares of the company’s stock at an average price of 3.08 for a total transaction amount of $2,730,352.24 SEC Form

Insider Trading History For BioScrip, Inc. (NASDAQ:BIOS)

  • On 11/13/2012 Stuart A Samuels, Director, sold 11,200 with an average share price of $9.66 per share and the total transaction amounting to $108,192.00.View SEC Filing
  • On 7/19/2013 Myron Z Holubiak, Director, sold 31,200 with an average share price of $16.34 per share and the total transaction amounting to $509,808.00.View SEC Filing
  • On 8/19/2013 Kohlberg Management V, Llc, Insider, sold 6,895,873 with an average share price of $13.00 per share and the total transaction amounting to $89,646,349.00.View SEC Filing
  • On 8/28/2013 Patricia Bogusz, VP, sold 39,687 with an average share price of $11.94 per share and the total transaction amounting to $473,862.78.View SEC Filing
  • On 8/28/2013 David Hubers, Director, sold 11,200 with an average share price of $12.23 per share and the total transaction amounting to $136,976.00.View SEC Filing
  • On 8/30/2013 Daniel Colucci, VP, sold 18,500 with an average share price of $12.40 per share and the total transaction amounting to $229,400.00.View SEC Filing
  • On 5/14/2014 Yon Jorden, Director, bought 5,000 with an average share price of $7.21 per share and the total transaction amounting to $36,050.00.View SEC Filing

    • Analyst Ratings For BioScrip, Inc. (NASDAQ:BIOS)
    These are 4 Buy Ratings .
    The current consensus rating for BioScrip, Inc. (NASDAQ:BIOS) is Buy (Score: 3.00) with a consensus target price of $3.94 , a potential (31.25% upside)

    Analyst Ratings History For BioScrip, Inc. (NASDAQ:BIOS)

    • On 3/5/2016 Stephens Reiterated Rating Buy
    • On 1/3/2017 Lake Street Capital Initiated Coverage of rating Buy with a price target of $4.50
    • On 6/26/2017 Barrington Research Boost Price Target of rating Outperform with a price target of $3.50
    • On 8/10/2017 Jefferies Group LLC Reiterated Rating Buy with a price target of $3.00 to $4.00
    • On 8/10/2017 SunTrust Banks, Inc. Upgraded rating Hold to Buy with a price target of $3.25 to $3.75

    Recent Trading Activity for BioScrip, Inc. (NASDAQ:BIOS)
    Shares of BioScrip, Inc. closed the previous trading session at 3.00 up +0.01 0.33% with 2,315,563 shares trading hands.